BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29108775)

  • 21. Overexpression of NQO1 protects human SK-N-MC neuroblastoma cells against dopamine-induced cell death.
    Zafar KS; Inayat-Hussain SH; Siegel D; Bao A; Shieh B; Ross D
    Toxicol Lett; 2006 Oct; 166(3):261-7. PubMed ID: 16978807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of NAD(P)H: Quinone Oxidoreductase 1 Inhibits Hepatocellular Carcinoma Cell Proliferation and Induced Apoptosis by Activating AMPK/PGC-1α Pathway.
    Zhang X; Han K; Yuan DH; Meng CY
    DNA Cell Biol; 2017 Apr; 36(4):256-263. PubMed ID: 28191864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antioxidant tert-butylhydroquinone ameliorates arsenic-induced intracellular damages and apoptosis through induction of Nrf2-dependent antioxidant responses as well as stabilization of anti-apoptotic factor Bcl-2 in human keratinocytes.
    Duan X; Li J; Li W; Xing X; Zhang Y; Li W; Zhao L; Sun G; Gao XH; Li B
    Free Radic Biol Med; 2016 May; 94():74-87. PubMed ID: 26878773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) and cytochrome P450 oxidoreductase (CYP450OR) differentially regulate menadione-mediated alterations in redox status, survival and metabolism in pancreatic β-cells.
    Gray JP; Karandrea S; Burgos DZ; Jaiswal AA; Heart EA
    Toxicol Lett; 2016 Nov; 262():1-11. PubMed ID: 27558805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53.
    Gong X; Kole L; Iskander K; Jaiswal AK
    Cancer Res; 2007 Jun; 67(11):5380-8. PubMed ID: 17545619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioactivation of Napabucasin Triggers Reactive Oxygen Species-Mediated Cancer Cell Death.
    Froeling FEM; Swamynathan MM; Deschênes A; Chio IIC; Brosnan E; Yao MA; Alagesan P; Lucito M; Li J; Chang AY; Trotman LC; Belleau P; Park Y; Rogoff HA; Watson JD; Tuveson DA
    Clin Cancer Res; 2019 Dec; 25(23):7162-7174. PubMed ID: 31527169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual pathways of p53 mediated glucolipotoxicity-induced apoptosis of rat cardiomyoblast cell: activation of p53 proapoptosis and inhibition of Nrf2-NQO1 antiapoptosis.
    Wang HJ; Lee EY; Han SJ; Kim SH; Lee BW; Ahn CW; Cha BS; Lee HC
    Metabolism; 2012 Apr; 61(4):496-503. PubMed ID: 22154326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated wound closure in a diabetic mouse model after exposure to phenanthrenequinone.
    Polack G; McCray V; Tyner T; Kane S; Vu K; Yamaguchi K; Merriman J; Ishimoto M; Hasson A; Sian K; Yamaguchi KT
    Ann Plast Surg; 2013 Jun; 70(6):720-5. PubMed ID: 22395047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic induces apoptosis of human umbilical vein endothelial cells through mitochondrial pathways.
    Shi Y; Wei Y; Qu S; Wang Y; Li Y; Li R
    Cardiovasc Toxicol; 2010 Sep; 10(3):153-60. PubMed ID: 20473585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of salt-induced renal injury by activation of NAD(P)H:quinone oxidoreductase 1, associated with NADPH oxidase.
    Kim YH; Hwang JH; Noh JR; Gang GT; Tadi S; Yim YH; Jeoung NH; Kwak TH; Lee SH; Kweon GR; Kim JM; Shong M; Lee IK; Lee CH
    Free Radic Biol Med; 2012 Mar; 52(5):880-8. PubMed ID: 22227174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidative enzyme NAD(P)H quinone oxidoreductase 1 (NQO1) modulates the differentiation of Th17 cells by regulating ROS levels.
    Nishida-Tamehiro K; Kimura A; Tsubata T; Takahashi S; Suzuki H
    PLoS One; 2022; 17(7):e0272090. PubMed ID: 35905076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of NAD(P)H:quinone oxidoreductase (NQO1) in apoptosis induction by aziridinylbenzoquinones RH1 and MeDZQ.
    Nemeikaite-Ceniene A; Dringeliene A; Sarlauskas J; Cenas N
    Acta Biochim Pol; 2005; 52(4):937-41. PubMed ID: 15940348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arachidonic acid-induced apoptosis of human neuroblastoma SK-N-SH cells is mediated through mitochondrial alteration elicited by ROS and Ca(2+)-evoked activation of p38alpha MAPK and JNK1.
    Chen KC; Chang LS
    Toxicology; 2009 Aug; 262(3):199-206. PubMed ID: 19540902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer.
    Wu X; Li X; Li Z; Yu Y; You Q; Zhang X
    J Med Chem; 2018 Dec; 61(24):11280-11297. PubMed ID: 30508483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector.
    Dinkova-Kostova AT; Talalay P
    Arch Biochem Biophys; 2010 Sep; 501(1):116-23. PubMed ID: 20361926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional regulation of the NAD(P)H:quinone oxidoreductase 1 and glutathione S-transferase ya genes by mercury, lead, and copper.
    Korashy HM; El-Kadi AO
    Drug Metab Dispos; 2006 Jan; 34(1):152-65. PubMed ID: 16243960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxicity of RH1: NAD(P)H:quinone acceptor oxidoreductase (NQO1)-independent oxidative stress and apoptosis induction.
    Tudor G; Alley M; Nelson CM; Huang R; Covell DG; Gutierrez P; Sausville EA
    Anticancer Drugs; 2005 Apr; 16(4):381-91. PubMed ID: 15746574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity.
    Joseph P; Long DJ; Klein-Szanto AJ; Jaiswal AK
    Biochem Pharmacol; 2000 Jul; 60(2):207-14. PubMed ID: 10825465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities.
    Ling Y; Yang QX; Teng YN; Chen S; Gao WJ; Guo J; Hsu PL; Liu Y; Morris-Natschke SL; Hung CC; Lee KH
    Eur J Med Chem; 2018 Jun; 154():199-209. PubMed ID: 29803003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of NAD(P)H:quinone oxidoreductase 1 gene expression by CYP1A1 activity.
    Marchand A; Barouki R; Garlatti M
    Mol Pharmacol; 2004 Apr; 65(4):1029-37. PubMed ID: 15044633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.